Chapter 87- Lung Cancer

Description:
IMPORTANT NOTE – PLEASE READ FIRST: This continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. Please go to our home page: http://www.rxugace.com/ and click on “Books” for more information Prior To Registering for this assessment.

Upon completion of the corresponding textbook chapter in Pharmacotherapy Principles & Practice and this on-line assessment, the reader should be able to:

1. Identify major risk factors for the development of lung cancer.
2. Explain the pathologic progression of lung cancer and its relationship with signs and symptoms of the disease.
3. Make appropriate recommendations for screening or preventative measures in high-risk patients.
4. Understand staging of lung cancer patients and how it influences treatment decisions.
5. List the rationale, advantages, disadvantages, and place in therapy for adjuvant and neoadjuvant chemotherapy
6. Identify the chemotherapeutic regimens of choice for limited and extensive small cell lung carcinoma, as well as local, locally advanced, and advanced non–small cell lung carcinoma.
7. Monitor patients for chemotherapy-associated toxicity, and recommend appropriate management.
8. Distinguish the treatment goals of palliative care versus those of first-line treatment.

Courses Offered